Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as $22.31 and last traded at $22.3650, with a volume of 1630988 shares traded. The stock had previously closed at $22.91.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on BBWI. Jefferies Financial Group dropped their price target on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research note on Monday, October 13th. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Morgan Stanley raised their price objective on shares of Bath & Body Works from $40.00 to $43.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Citigroup reduced their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Finally, Wells Fargo & Company dropped their price target on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, October 27th. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $38.18.
Check Out Our Latest Research Report on Bath & Body Works
Bath & Body Works Price Performance
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the company posted $0.37 EPS. The business’s quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be paid a $0.20 dividend. The ex-dividend date is Friday, November 21st. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. Bath & Body Works’s payout ratio is currently 23.74%.
Institutional Investors Weigh In On Bath & Body Works
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Parkside Financial Bank & Trust boosted its position in shares of Bath & Body Works by 24.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after purchasing an additional 364 shares in the last quarter. Parallel Advisors LLC raised its stake in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after buying an additional 481 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Bath & Body Works by 3.7% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after acquiring an additional 600 shares in the last quarter. Natixis Advisors LLC grew its stake in Bath & Body Works by 0.7% in the first quarter. Natixis Advisors LLC now owns 90,089 shares of the company’s stock valued at $2,732,000 after acquiring an additional 629 shares during the period. Finally, State of Wyoming increased its holdings in shares of Bath & Body Works by 6.2% during the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock valued at $338,000 after acquiring an additional 661 shares in the last quarter. 95.14% of the stock is owned by institutional investors.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
- Five stocks we like better than Bath & Body Works
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Monday.com Opens Generational Opportunity With Manic Sell-Off
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- An Earnings Win With a Stock Slump: What’s Happening With D-Wave?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Stocks Showing Relative Strength as Markets Pull Back
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
